QTTB (Q32 Bio) Other Current Liabilities : $6.15 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Q32 Bio Other Current Liabilities?

Q32 Bio's other current liabilities for the quarter that ended in Sep. 2024 was $6.15 Mil.

Q32 Bio's quarterly other current liabilities declined from Mar. 2024 ($9.49 Mil) to Jun. 2024 ($7.77 Mil) and declined from Jun. 2024 ($7.77 Mil) to Sep. 2024 ($6.15 Mil).

Q32 Bio's annual other current liabilities increased from Dec. 2021 ($1.49 Mil) to Dec. 2022 ($2.79 Mil) and increased from Dec. 2022 ($2.79 Mil) to Dec. 2023 ($3.00 Mil).

Q32 Bio Other Current Liabilities Historical Data

The historical data trend for Q32 Bio's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q32 Bio Other Current Liabilities Chart

Q32 Bio Annual Data

Trend

Dec21

Dec22

Dec23

Other Current Liabilities

Q32 Bio Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Current Liabilities	Get a 7-Day Free Trial					-	-	-	-	-

Q32 Bio Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Q32 Bio Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Q32 Bio's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Q32 Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q32 Bio Inc (NAS:QTTB) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

DB0:Germany

Address

830 Winter Street, Waltham, MA, USA, 02451

Website

https://www.q32bio.com

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.